Showing 4951-4960 of 5608 results for "".
Private Equity’s Uncertain Arc in Ophthalmology
https://crstoday.com/topics/practice-management/private-equitys-uncertain-arc-in-ophthalmology/45352/Unexpected challenges have disrupted the game plan.Should Latent Hyperopia Be Considered a Lens-Dysfunction Phenotype?
https://crstoday.com/crst-issues/mar-2026/should-latent-hyperopia-be-considered-a-lens-dysfunction-phenotype/56591/When refractive lens exchange is the more durable solution.Matching Eye, Optic, and Expectations
https://crstoday.com/crst-issues/feb-2026/matching-eye-optic-and-expectations/56580/My decision-making framework for presbyopia-correcting IOLs.Phakic IOLs in 2025
https://crstoday.com/crst-issues/may-2025/phakic-iols-in-2025/45494/Expanded candidacy, improved safety, and smarter sizingNavigating Workforce and Financial Challenges
https://crstoday.com/crst-issues/feb-2025/navigating-workforce-and-financial-challenges/45440/Exploring Dry Eye Disease in Microgravity
https://crstoday.com/topics/ocular-surface-disease/exploring-dry-eye-disease-in-microgravity/45351/What happens to the ocular surface in space?Gene Therapy for the Retina
https://crstoday.com/crst-supplements/an-inside-look-at-innovations-in-ophthalmology-june-2024/gene-therapy-for-the-retina/45315/Small-Aperture Premium IOLs
https://crstoday.com/crst-supplements/an-inside-look-at-innovations-in-ophthalmology-march-2024/small-aperture-premium-iols/45257/A Need for Scientific Rigor
https://crstoday.com/crst-issues/mar-2024/a-need-for-scientific-rigor/45248/Manus C. Kraff, MD, a founding member and past president (1983–1985) of the ASCRS, reflects on the organization’s early days.The Potential of Fibroblast Growth Factors in Corneal Disease
https://crstoday.com/crst-supplements/an-inside-look-at-innovations-in-ophthalmology-january-2024/the-potential-of-fibroblast-growth-factors-in-corneal-disease/45210/